165 - From Lab Bench to Pilot Plant: Navigating the Challenges of Chemical Process Scale-Up (S11E15)

Welcome to the Deep Dive. You're joining us as
we explore a really pivotal moment in bringing
new medicines to the world. Yeah, that leap,
right? From a promising lab discovery to actual
full -scale manufacturing. Exactly. I mean, think
about it. A chemical reaction perfected in a
tiny flask suddenly needs to be replicated in
reactors? What? thousands of times larger? It's
a huge jump. And it matters so much because,
well, without mastering the scale up, those early
breakthroughs, they just stay breakthroughs on
paper. They don't actually reach pharmacies.
That's a really key point. You're talking about
a transformation where the chemistry itself,
elegant on a small scale, suddenly faces all
these new challenges as the quantities just explode.
Precisely. And for our listeners who want to
grasp the core issues, but maybe without getting
totally bogged down in excessive detail, this
is really what this deep dive is for. Right.
We've tried to distill the essential stuff from,
well, a whole range of sources, from high level
strategy guides down to the real nitty gritty
of pharmaceutical science. You know, to shine
a light on the crucial things to consider and
also the potential hazards. in that scale -up
journey. So our mission today is to give you
a clear understanding of what it really takes
to make this jump successfully. We're focusing
on, I guess, three main pillars. Sounds about
right. OK, so a really solid understanding of
the chemical process itself, making smart choices
about the equipment for the job. having a deep
appreciation for how things like reaction kinetics
and thermodynamics behave in these massive systems.
Absolutely critical areas. And we'll also keep
an eye out for any clues in our sources about
how specific drugs, maybe like gastrozole or
lower Latin have actually navigated the stage.
So consider this your shortcut, yeah, to understanding
a part of drug development that's often behind
the scenes, but it's just, well, fundamental.
Let's do it. Where should we start? Process understanding.
Yeah, let's unpack that. Why? is understanding
the process at that fundamental level even more
crucial when you're going big. Well, what's fascinating
here is how these like subtle behaviors of molecules,
things you might barely notice at lab scale,
they get magnified and potentially become real
problems as you scale up. OK. So a cornerstone
of this process understanding is really getting
to grips with these solid state properties. of
the actual drug substance. Solid state property,
like how the drug exists as a solid. Exactly.
The way a molecule arranges itself in its solid
form. Is it a specific crystal structure that's
called a polymorph? Or does it incorporate solvent
molecules, making it a solvent? Or maybe it forms
a salt. These things can have Well, profound
effects. Profound how? What kind of effects are
we talking about? Big ones. We're talking about
impacting how well it dissolves in the body,
its stability over time, and even how easily
it could actually be processed into a pill later
on. Huh. So it's almost like... Like the same
Lego bricks can be clicked together in different
ways and those different arrangements end up
having totally different properties That's a
perfect analogy. Yeah, and here's where a potentially
huge pitfall comes in Imagine you've developed
your whole lab process around one specific crystal
form Then as you start scaling up maybe in a
bigger reactor with different conditions You
suddenly discover a new more stable polymorph
starts forming more stable sounds good, though
Isn't stability what you want? You'd think so.
But more stable often means it dissolves much
more slowly. So this new form could actually
make your drug much less effective once it's
in the body. Ah, OK. So your super strong Lego
castle keeps collapsing because the bricks are
slightly different when you build it bigger.
Exactly like that. And finding that out late
in development, that can cause massive delays,
a real timeline killer, like you said earlier,
and a huge financial hit. Wow, yeah, that makes
perfect sense. Okay, so polymorphism is one big
thing. What other aspects of the chemical process
really need that closer look during scale -up?
Another really critical area is the interplay
between anhydrous, meaning water -free, and hydrated
or water -containing forms of a drug. Right,
water content. Yeah, the ability of a drug molecule
to kind of grab onto or lose water molecules
can dramatically affect both its bioavailability
how it's drug actually gets into the bloodstream
and it's long -term stability on the shelf. Okay.
So understanding and controlling those transitions
especially under the different conditions you
might find in large -scale manufacturing is just
vital for ensuring you get consistent product
quality every time. It's like needing to know
if your building materials are going to warp
or change shape depending on the humidity. That's
a good way to put it. Yeah. So even something
seemingly simple like the presence or absence
of water can really throw a wrench in the works
if you're not careful. Okay, got it. Polymorphs,
hydrates, anything else under this process understanding
umbrella. Absolutely. We definitely need to talk
about the art and science of crystallization,
getting the crystallization process right. Well,
it's described as a complex balancing act. It
has huge implications for, like, Everything.
The cost of making the drug, the safety of the
process, the drug's actual effectiveness, and
just how easy it is to handle and process the
final drug substance. So getting the crystals
right matters a lot. Oh, massively. Think about
it. Yeah. Nice, well -formed crystals are easier
to filter, easier to dry, easier to handle downstream.
They might even reduce the need for, say, energy
-intensive milling steps later. Okay. But maybe
more importantly, the actual size and shape of
those crystals can directly influence how the
drug behaves in the body when the patient takes
it. How so? Well. A poorly controlled crystallization
might give you tiny dusty particles that are
really difficult to handle safely, or maybe it
gives you large irregular crystals that just
don't dissolve properly once they're ingested.
Right. Affecting bioavailability again. Exactly.
So really deeply understanding all the factors
that influence how those crystals form. Temperature,
solvent, mixing speed, cooling rate, all of it
is just paramount for a smooth and successful
scale up. So that deep understanding of the process.
that then feeds directly into the next big thing,
right? Equipment selection. Precisely. Because
moving from, you know, a little beaker on a lab
bench to a tank the size of a small car, well,
isn't just a matter of multiplying everything
by a thousand, is it? I'm guessing not. Not at
all. Lab equipment is usually designed for small
volumes. Thinking about ease of use for a chemist,
maybe. Yeah. It often just doesn't translate
well to the challenges of larger scales. Right,
what kind of challenges? Well, heat transfer.
for one, becomes a major hurdle, a reaction that
generates a bit of heat. You can easily cool
that in a small lab flask surrounded by an ice
bath, maybe. Sure. But in a huge reactor, that
same amount of heat proportionally can build
up really fast. If you can't remove it efficiently,
you risk dangerous runaway reactions, or maybe
just forming unwanted impurities because it got
too hot. OK. That sounds serious. It is. And
mixing, too. Getting uniform mixing throughout
a vast volume, that needs specialized equipment
like specific impeller designs and motor power.
It's way beyond a simple magnetic stir bar. Right.
You need everything reacting consistently. You
do. Ensuring consistent reaction conditions,
temperature, concentration, mixing throughout
the entire batch is crucial for maintaining product
quality. And of course, safety. protocols just
become exponentially more critical when you're
dealing with industrial quantities of chemicals.
So how do companies actually bridge that gap?
How do they handle the jump in scale when it
comes to the actual hardware, the equipment?
Yeah, so this is where the idea of a pilot plant
becomes really invaluable. A pilot plant? Like
a smaller version of the final factory? Kind
of. Think of it as a crucial intermediate stage.
It's a testing ground, somewhere between the
lab bench and full -scale commercial manufacturing.
By running the reactions at a scale that's bigger
than the lab but still smaller than full production,
companies can identify and sort out potential
issues, problems related to equipment performance,
process parameters, and find them before committing
to those massive investments in the final plan.
That makes sense. Test the waters first. Exactly.
And the key thing is that the equipment you choose,
both for the pilot plant and then for the eventual
commercial facility, it has to be directly aligned
with those critical process parameters you identified
earlier during that deep dive into process understanding.
Ah, it all links back. It has to. You need to
be sure that the reactors, mixers, pumps, heat
exchangers, whatever you choose, that they are
actually capable of reliably maintaining the
necessary conditions for a safe efficient and
consistent reaction. It really sounds like a
significant upfront investment in Planning and
well infrastructure is absolutely necessary.
You can't just wing it No, definitely not and
the facility itself plays a critical role, too
Especially in what's called a GMP environment
good manufacturing practice right the quality
standards Yeah, the actual design of the manufacturing
building is paramount to prevent things like
contamination or mix -ups between different products
or batches how well everything from the flow
of materials and people through the building
to How different processing areas are segregated?
It's all carefully considered to support the
scaled up process and ultimately guarantee the
quality and safety of the final drug product.
Wow. Okay. So process understanding feeds equipment
selection and the facility design supports both.
What about the underlying chemistry itself? You
mentioned kinetics and thermodynamics earlier.
How do they change with scale? That's a great
question. And yeah, they become much more influential,
much more visible, let's say, at scale. Reaction
rate, that's the kinetics part and the position
of equilibrium, which is thermodynamics. Both
can be affected by just is changing the scale.
How? Well, think about that heat transfer issue
again. As the size of your reactor increases,
the surface area available for heating or cooling
doesn't increase as fast as the volume inside.
That surface area to volume ratio actually decreases.
So that can impact the efficiency of anything
that relies on surface interactions, maybe certain
types of catalysts. Or again, it directly impacts
your ability to get heat into or more often out
of the system, effectively. So a reaction that's
like, lightning fast in a test tube might actually
take significantly longer or maybe overheat in
a huge reactor just because the heat can't get
in or out quickly enough. Precisely. Or it might
run too slowly if it needs heat input. And this
is where really understanding the thermodynamics
basically does the reaction release heat or consume
heat. is absolutely crucial. Especially heat
-releasing ones, I imagine. Exothermic. Exactly.
Exothermic reactions, the ones that release heat,
pose a much greater risk at larger scales. If
that heat isn't removed efficiently, the reaction
temperature can just skyrocket. Leading to? Well,
best case, maybe just formation of unwanted,
potentially dangerous byproducts because side
reactions kick off at higher temperatures. Worst
case, runaway reactions, pressure buildup. even
explosions. Right. Yeah. And this really highlights
the absolute necessity of having robust process
control and monitoring systems in commercial
manufacturing. You need sensors, automated controls,
safety interlocks, all designed to keep those
critical factors like temperature, pressure,
addition rates within very tight safe operating
ranges. So it's not just about making a lot of
the drug. It's about doing it safely and getting
the same quality batch after batch after batch.
That's the essence of it. Consistency and safety
at scale. Now, we mentioned earlier, possibly
looking for examples like, um, Gastrozole and
Lorlatinib. Did our sources happen to give any
specific details about how the synthesis of those
particular drugs was successfully scaled up?
Any war stories? You know, unfortunately, the
specific nitty -gritty details about the scale
-up for Gastrozole and Lorlatinib weren't really
elaborated on in the materials we looked at for
this deep dive. Ah, okay. Shame. It is. But the
broader point here is still incredibly important.
The pharmaceutical industry will... It relies
heavily on the accumulated knowledge from countless
successful and sometimes unsuccessful scale -up
stories over the decades. Learning from experience.
Exactly. So while we don't have the specifics
of those two examples right here today, the principles
we've been discussing, that critical importance
of deep process understanding, careful equipment
selection tailored to the scale, and that thorough
grasp of kinetics and thermodynamics, they're
all informed by those successes. by that collective
experience. Studying how others have navigated
these challenges, even if it's internal company
knowledge sometimes, provides invaluable lessons
and helps establish the best practices for bringing
new medicines to patients effectively. So even
without the specific blow -by -blow for those
drugs, the framework we've kind of built up here
is based on the collective wisdom of the industry
tackling these very issues over and over. Precisely.
And that collective experience has also definitely
highlighted some common pitfalls, things that
frequently trip people up during scale -up. Okay,
let's talk pitfalls. What are some of the typical
headaches that drug developers run into when
they try to move to large -scale production?
Well, one really frequent issue is the sudden
appearance of unexpected impurities. Impurities,
where do they come from? They can arise from
subtle changes in reaction conditions, maybe
slightly longer reaction times, or slightly different
temperature profiles in a big reactor compared
to the lab flask. Or they might come from the
materials used to build the larger reactors,
leaching something tiny. Even slight variations
in the quality of the raw materials can sometimes
lead to byproducts that were completely insignificant,
maybe even undetectable, at the smaller lab scale.
Huh. So stuff you didn't even know was there
can suddenly become a problem. Right. And then
just maintaining consistent product quality across
these vastly larger batches is another significant
hurdle. Even with really well -defined processes
and sophisticated equipment, minor variations
can creep in, ensuring that every single batch
meets the rigorous quality standards that demands
incredibly meticulous monitoring and control
systems. And we talked about this earlier, but
those solid state properties, the crystals and
hydrates, they can also cause headaches again
at larger scales, can't they? Well, absolutely.
As we discussed, maybe the crystallization process
behaves slightly differently at scale, leading
to changes in polymorphism, or maybe the drying
process leads to a different hydrate form, or
even just subtle shifts in the particle size
distribution. And that matters because... Because
it can have a significant impact on the drug's
performance in the body. It's bioavailability,
it's stability, even how it gets formulated into
the final pill or capsule. What worked perfectly
in a small lab batch might suddenly exhibit completely
different characteristics when you produce it
at commercial scale. So you might have to reformulate
everything. Potentially. And we also mustn't
forget the escalating safety risks. You're handling
much, much larger volumes of potentially hazardous
chemicals, solvents, intermediates. So implementing
really robust safety protocols, engineering controls
like ventilation and containment, and having
solid emergency procedures is just paramount.
Makes sense. And then finally, even if you overcome
all the technical chemistry and engineering challenges,
the regulatory agencies are watching closely.
Ah, the regulatory hurdles. Yeah, they meticulously
scrutinize any changes made to the manufacturing
process during scale up because any change could
potentially affect the safety or efficacy of
the final drug. You have to prove that the scaled
up process delivers equivalent product. So, wow,
scaling up really isn't just a feat of engineering,
is it? It's this complex interplay of chemistry,
engineering, safety, quality control, and regulatory
compliance all moving together. That's a very
astute summary. Yeah. Yeah, it truly demands
a holistic approach and just unwavering attention
to detail at absolutely every stage. OK. So as
we kind of wrap up our deep dive into this really
critical stage of drug development, what are
the absolute key takeaways, the main considerations
you'd want to leave our listeners with about
successfully scaling up chemical synthesis? I
think the crucial elements boil down to these.
First, a really comprehensive fundamental understanding
of the chemical process itself, knowing its ins
and outs intimately. Second, a strategic and
informed selection of equipment that is genuinely
fit for purpose at the required scale. And third,
a thorough grasp of how the reaction kinetics
and thermodynamics are going to behave in those
larger systems so you can ensure both efficiency
and safety. Those three pillars. It's definitely
clear that while it's often unseen by most of
us, the ability to successfully scale up chemical
synthesis is an absolutely essential step and
frankly, an incredibly complex one in making
new and potentially life -saving medicines available
to people. Indeed it is. And you know, considering
all the intricate details we've touched on today,
everything from that subtle dance of molecules
arranging themselves in different crystal forms
to the immense engineering challenges of building
and running industrial scale reactors and managing
that delicate balance of chemical reactions at
huge volumes. What does that tell you? Tell me
about. About the sheer dedication, the incredible
effort, the layers of complexity that go into
bringing even a single seemingly simple pill
to the pharmacy shelf. And maybe what further
questions does this deep dive spark in your mind
about that whole incredible journey a drug takes.
From that initial spark of discovery all the
way to ultimately reaching the patients who need
it.